東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Pharmacokinetic/pharmacodynamic mode...

Hazra-Raybon, Anasuya.

Linked to FindBook

Google Book

Amazon

博客來

Pharmacokinetic/pharmacodynamic modeling of selected receptor/gene mediated effects of corticosteroids.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Pharmacokinetic/pharmacodynamic modeling of selected receptor/gene mediated effects of corticosteroids./
Author:	Hazra-Raybon, Anasuya.
Description:	390 p.
Notes:	Adviser: William J. Jusko.
Contained By:	Dissertation Abstracts International67-11B.
Subject:	Health Sciences, Pharmacology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3244230
ISBN:	9780542998140

Pharmacokinetic/pharmacodynamic modeling of selected receptor/gene mediated effects of corticosteroids.
Hazra-Raybon, Anasuya.

Pharmacokinetic/pharmacodynamic modeling of selected receptor/gene mediated effects of corticosteroids. - 390 p.

Adviser: William J. Jusko.

Thesis (Ph.D.)--State University of New York at Buffalo, 2007.

The receptor/gene mediated effects of corticosteroids (CS) on various metabolic pathways were studied using pharmacokinetic/pharmacodynamic (PK/PD) modeling. A modified model for glucocorticoid receptor (GR) dynamics in adrenalectomized (ADX) rats was proposed by integrating available in vitro and in vivo literature data on GR dynamics, which was then applied to characterize the effects of acute and chronic CS on the greater urea cycle genes. To examine the feasibility of replacing ADX rats with intact rats to investigate CS metabolic effects, a circadian rhythm study was performed. This study, besides confirming daily variation in endogenous corticosterone (CST), also determined daily fluctuations in several CS biomarkers related to gluconeogenesis and lipid metabolism, e.g., hepatic GR, tyrosine aminotransferase (TAT) dynamics, low-density lipoprotein receptor (LDLR) and various plasma lipid levels, total cholesterol (TC), LDL-cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC) and triglycerides (TG). A quantitative structure property relationship (QSPR)-PD model was developed to integrate the effects of different CS in ADX rats with the circadian rhythm of CST in intact rats in controlling the expression of a hepatic TAT. The PK of 50 mg/kg of MPL after IM dosing in rats showed approximately 50% bioavailability and complex absorption characteristics which was described by two different first-order absorption pathways. The GR and TAT regulation by MPL in normal rats showed more complexity compared to ADX rats. An integrated PK/PD model incorporating components from the 5th-generation and the QSPR-PD model successfully captured the complex interplay of the endogenous and exogenous CS in regulating both hepatic GR and TAT dynamics. Lastly, to initiate an effort to examine one of the major metabolic side effects of CS, premature risks of atherosclerosis, the effects of MPL on hepatic LDLR dynamics and plasma lipids were determined. The down-regulation of LDLR mRNA by MPL was hypothesized to cause an increase in plasma cholesterols. A comprehensive PK/PD model, based upon this hypothesis, characterized the lipid as well as LDLR mRNA dynamics. Overall, this dissertation broadened our knowledge on receptor/gene mediated PK/PD of CS in a more clinically relevant animal model and provided a foundation for further exploration of CS mediated adverse effects on lipid metabolism.

ISBN: 9780542998140Subjects--Topical Terms:

1017717
Health Sciences, Pharmacology.

Pharmacokinetic/pharmacodynamic modeling of selected receptor/gene mediated effects of corticosteroids.
LDR:03350nam 2200277 a 45 001 964092
005 20110901
008 110901s2007 eng d
020 $a 9780542998140
035 $a (UMI)AAI3244230
035 $a AAI3244230
040 $a UMI $c UMI
100 1 $a Hazra-Raybon, Anasuya. $3 1287163
245 1 0 $a Pharmacokinetic/pharmacodynamic modeling of selected receptor/gene mediated effects of corticosteroids.
300 $a 390 p.
500 $a Adviser: William J. Jusko.
500 $a Source: Dissertation Abstracts International, Volume: 67-11, Section: B, page: 6332.
502 $a Thesis (Ph.D.)--State University of New York at Buffalo, 2007.
520 $a The receptor/gene mediated effects of corticosteroids (CS) on various metabolic pathways were studied using pharmacokinetic/pharmacodynamic (PK/PD) modeling. A modified model for glucocorticoid receptor (GR) dynamics in adrenalectomized (ADX) rats was proposed by integrating available in vitro and in vivo literature data on GR dynamics, which was then applied to characterize the effects of acute and chronic CS on the greater urea cycle genes. To examine the feasibility of replacing ADX rats with intact rats to investigate CS metabolic effects, a circadian rhythm study was performed. This study, besides confirming daily variation in endogenous corticosterone (CST), also determined daily fluctuations in several CS biomarkers related to gluconeogenesis and lipid metabolism, e.g., hepatic GR, tyrosine aminotransferase (TAT) dynamics, low-density lipoprotein receptor (LDLR) and various plasma lipid levels, total cholesterol (TC), LDL-cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC) and triglycerides (TG). A quantitative structure property relationship (QSPR)-PD model was developed to integrate the effects of different CS in ADX rats with the circadian rhythm of CST in intact rats in controlling the expression of a hepatic TAT. The PK of 50 mg/kg of MPL after IM dosing in rats showed approximately 50% bioavailability and complex absorption characteristics which was described by two different first-order absorption pathways. The GR and TAT regulation by MPL in normal rats showed more complexity compared to ADX rats. An integrated PK/PD model incorporating components from the 5th-generation and the QSPR-PD model successfully captured the complex interplay of the endogenous and exogenous CS in regulating both hepatic GR and TAT dynamics. Lastly, to initiate an effort to examine one of the major metabolic side effects of CS, premature risks of atherosclerosis, the effects of MPL on hepatic LDLR dynamics and plasma lipids were determined. The down-regulation of LDLR mRNA by MPL was hypothesized to cause an increase in plasma cholesterols. A comprehensive PK/PD model, based upon this hypothesis, characterized the lipid as well as LDLR mRNA dynamics. Overall, this dissertation broadened our knowledge on receptor/gene mediated PK/PD of CS in a more clinically relevant animal model and provided a foundation for further exploration of CS mediated adverse effects on lipid metabolism.
590 $a School code: 0656.
650 4 $a Health Sciences, Pharmacology. $3 1017717
650 4 $a Health Sciences, Pharmacy. $3 1017737
690 $a 0419
690 $a 0572
710 2 0 $a State University of New York at Buffalo. $3 1017814
773 0 $t Dissertation Abstracts International $g 67-11B.
790 $a 0656
790 1 0 $a Jusko, William J., $e advisor
791 $a Ph.D.
792 $a 2007
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3244230